Persistent hypertriglyceridemia in statin-treated patients with type 2 diabetes mellitus
Michael Feher,1–3 Mark Greener,4 Neil Munro1–3,51Beta Cell Diabetes Centre, Chelsea and Westminster Hospital, London, 2Diabetes Therapies Evaluation Network, London, 3CSRI, Warwick University, Warwick, 4ROCK Medical Communications, Richmond, 5Department of Health Care Man...
Guardado en:
Autores principales: | Feher M, Greener M, Munro N |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
Dove Medical Press
2013
|
Materias: | |
Acceso en línea: | https://doaj.org/article/4c3527219a6b492195168abc1ed0c729 |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
Saroglitazar for the treatment of hypertriglyceridemia in patients with type 2 diabetes: current evidence
por: Sosale A, et al.
Publicado: (2015) -
Treating statin-intolerant patients
por: Pigna G, et al.
Publicado: (2011) -
Pioglitazone improves the cardio-ankle vascular index in patients with type 2 diabetes mellitus treated with metformin
por: Ohira M, et al.
Publicado: (2014) -
Hypertriglyceridemia-Related Pancreatitis In Patients With Type 2 Diabetes: Links And Risks
por: Shemesh E, et al.
Publicado: (2019) -
Effect of different doses of statins on the development of type 2 diabetes mellitus in patients with myocardial infarction
por: Gruzdeva O, et al.
Publicado: (2017)